Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial - Concepedia

Concepedia

Publication | Open Access

Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial

DOI Full Paper Access

98

Citations

22

References

2018

Year

Matteo S. Carlino, Georgina V. Long, Dirk Schadendorf, Caroline Robert, Antoni Ribas, Erika Richtig, Marta Nyakas, Christian Caglevic, Ahmed Tarhini, Christian U. Blank,

European Journal of Cancer

Abstract

NCT01866319.

References

	Year	Citations

Page 1